Funder: American Association for Cancer Research
Due Dates (Anticipated): June 2026 (Letter of Intent) | October 2026 (Full application)
Funding Amounts: $400,000 total over 2 years; no indirect costs allowed.
Summary: Supports early- to mid-career investigators conducting innovative, high-impact cancer research with transformative clinical potential.
Key Information: This is a forecasted opportunity; all dates are projected and subject to change.